Morris Capital Advisors’s Celgene Corp CELG Stock Holding History

Morris Capital Advisors’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-26,386	Closed	-$2.35M	–	79
2018 Q1	$2.35M	Sell	26,386 -1,257	-5%	-$121K	1.56%	29
2017 Q4	$2.88M	Sell	27,643 -4,887	-15%	-$551K	1.88%	26
2017 Q3	$4.74M	Sell	32,530 -581	-2%	-$79.1K	3.17%	10
2017 Q2	$4.3M	Sell	33,111 -1,425	-4%	-$175K	3.03%	14
2017 Q1	$4.3M	Sell	34,536 -4,491	-12%	-$537K	3.12%	9
2016 Q4	$4.52M	Sell	39,027 -6,320	-14%	-$704K	3.14%	10
2016 Q3	$4.74M	Sell	45,347 -4,573	-9%	-$495K	2.94%	15
2016 Q2	$4.92M	Buy	49,920 +7,906	+19%	+$818K	2.92%	14
2016 Q1	$4.21M	Buy	42,014 +1,114	+3%	+$115K	2.85%	16
2015 Q4	$4.9M	Buy	+40,900	New	+$4.73M	3.41%	8

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morris Capital Advisors's CELG Position: Q2 2018 in Review

Morris Capital Advisors sold out of Celgene Corp (CELG) in Q2 2018, closing a stake of 26,386 shares — an estimated $2.35M sold.

Morris Capital Advisors first reported a position in CELG in Q4 2015 and held it in 10 quarters. The position peaked at $4.92M in Q2 2016. 1,360 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

Morris Capital Advisors reported no remaining Celgene Corp position as of Q2 2018 after selling out during the quarter.
Morris Capital Advisors sold 26,386 Celgene Corp shares in Q2 2018, an estimated $2.35M.
Morris Capital Advisors first reported a position in Celgene Corp in Q4 2015 and held it in 10 quarters.
Morris Capital Advisors's Celgene Corp position peaked at $4.92M in Q2 2016.
1,360 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on Morris Capital Advisors's 13F filing for Q2 2018, filed 13 Aug 2018.